Results 221 to 230 of about 64,337 (253)
Some of the next articles are maybe not open access.

HLA and testicular cancer

Nature, 1979
HLA IS involved not only in transplantation, but is also associated with many disease states. This first became evident when the major histocompatibility complex of the mouse (H–2) was shown to play a major part in determining resistance to Gross leukaemia virus1.
W C, DeWolf   +3 more
openaire   +2 more sources

Management of Testicular Cancer

JCO Oncology Practice
Testicular cancer is the most common malignancy in males age 15-40 years and one of the most curable cancers, with a cumulative 10-year survival rate exceeding 90%. Management strategies depend on the histologic subtype, stage at diagnosis, sites of disease, tumor markers, and risk classification. Germ cell tumors, including seminomas and nonseminomas,
Daniele Raggi   +12 more
openaire   +2 more sources

[Chemotherapy of testicular cancer].

Nederlands tijdschrift voor geneeskunde, 1999
Contains fulltext : 123769.pdf (Publisher’s version ) (Closed access)
Witjes, J.A., Debruyne, F.M.J.
openaire   +2 more sources

Testicular Cancer Survivorship

Hematology/Oncology Clinics of North America, 2011
Because of a rising incidence of, and declining mortality from, testicular cancer, there are an increasing number of survivors of testicular cancer. Given their young age at diagnosis, the survivors have many years of life ahead of them during which they may experience adverse consequences from cancer and its treatment.
openaire   +2 more sources

The Management of Testicular Cancer

1983
Testicular neoplasms are rare tumors that account for only about 1% of all cancers occurring in males and have an average annual incidence of about 2.3 per 100,000 males in the English-speaking population [19, 32]. Nevertheless, these tumors have a dramatic impact because they occur predominantly in young men.
openaire   +2 more sources

Testicular Cancer

Urologic Clinics of North America, 2015
openaire   +2 more sources

Testicular Cancer

Annual Review of Medicine, 1981
D G, Skinner   +2 more
openaire   +2 more sources

PET in Testicular Cancer

2011
Testicular cancer is a rare tumor, subdivided into seminomatous and nonseminomatous tumors. Whereas there are no serum tumor markers in the first group, they are present in nonseminomatous tumors, and are also important prognostic factors. Overall, the prognosis for testicular cancers is good, which makes the choice of accurate treatment intensity ...
openaire   +2 more sources

Treatment of Testicular Tumors

Ca-A Cancer Journal for Clinicians, 1967
J J Kaufman
exaly   +2 more sources

Home - About - Disclaimer - Privacy